Preview

Rational Pharmacotherapy in Cardiology

Advanced search

COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION

https://doi.org/10.20996/1819-6446-2010-6-1-89-94

Full Text:

Abstract

Advantages of combined therapy of patients with arterial hypertension are considered. Special attention is paid to usage of ACE inhibitor and calcium antagonist combination.

About the Authors

S. A. Boitsov
Russian Cardiology Research and Production Complex
Russian Federation
Tretya Cherepkovskaya ul. 15a, Moscow, 121552


R. M. Linchak
National Medico-Surgical Center named after N.I. Pirogov
Russian Federation
Nizhnya Pervomayskaya ul. 70, Moscow, 105203


References

1. Диагностика и лечение артериальной гипертензии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов (третий пересмотр). Кардиоваскулярная терапия и профилактика 2008; 7(6 Приложение 2):1-32.

2. Mancia G., De Backer G., Dominiczak A. et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007;25(9):1751-62.

3. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157(21):2413-46.

4. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999;17(2):151-85.

5. Jönsson B., Hansson L., Stålhammar N.O. Health economics in the Hypertension Optimal Treatment (HOT) study: costs and cost-effectiveness of intensive blood pressure lowering and lowdose aspirin in patients with hypertension. J Intern Med 2003;253(4):472-80.

6. Гостева Н.А., Жирова Л.Г., Линчак Р.М., Бойцов С.А. Лечат ли врачи свою артериальную гипертензию? Возможности комбинированной гипотензивной терапии. Вестник Национального медико-хирургического комплекса им. Н.И. Пирогова 2008;3(1):93-100.

7. Pepine C.J., Handberg-Thurmond E., Marks R.G. et al. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension. J Am Coll Cardiol 1998;32(5):1228-37.

8. Dahlöf B., Sever P.S., Poulter N.R. et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding ben￾droflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366(9489):895–906.

9. Nichols W.W. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens 2005;18(1 Pt 2):3S-10S

10. Kohara K., Tabara Y., Oshiumi A. et al. Radial augmentation index: a useful and easily obtainable parametr for vascular aging. Am J Hypertens 2005;18(1 Pt 2):11S-14S.

11. Weder A.B. The Avoiding Cardiovascular events through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a comparison of first-line combination therapies. Expert Opin Pharmacother 2005;6(2):275-81.


For citation:


Boitsov S.A., Linchak R.M. COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION. Rational Pharmacotherapy in Cardiology. 2010;6(1):89-94. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-1-89-94

Views: 333


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)